Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bio-Rad Laboratories
(NY:
BIO
)
325.13
-1.20 (-0.37%)
Streaming Delayed Price
Updated: 10:05 AM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bio-Rad Laboratories
< Previous
1
2
3
4
5
6
Next >
Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer
Today 8:30 EDT
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Second-Quarter 2024 Financial Results
August 01, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024
July 17, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
S&P 500 Ends First Half Shy Of All-Time Highs. Here Are The Leaders And Laggards — And 5 Stocks That Could Outperform In Next 6 Months
June 30, 2024
The market's resilient run has made traders cautious of a potential correction, but analysts remain optimistic about its trajectory.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Analyst Landscape: 4 Takes On Bio-Rad Laboratories
May 08, 2024
Via
Benzinga
OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Via
AB Newswire
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Chronic conditions such as organ transplant rejection and cancer represent significant challenges in modern healthcare, demanding precise diagnostic tools for effective management and treatment. For...
Via
TheNewswire.com
Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group
May 30, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference
May 23, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Laboratories: Q4 Earnings Insights
February 15, 2024
Via
Benzinga
Earnings Scheduled For February 15, 2024
February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.
Via
Benzinga
Preview: Bio-Rad Laboratories's Earnings
February 14, 2024
Via
Benzinga
BIO Stock Earnings: Bio-Rad Laboratories Beats EPS, Misses Revenue for Q1 2024
May 07, 2024
BIO stock results show that Bio-Rad Laboratories beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Bio-Rad Reports First-Quarter 2024 Financial Results
May 07, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference
May 01, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Announces Life Science Group Management Changes
April 26, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity?
April 18, 2024
480 out of 500 S&P 500 companies are trading below analysts' price targets, indicating potential profit opportunities. April has been bleak for the market, but some undervalued stocks may be worth...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
April 18, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad’s Chief Operating Officer Andrew Last to Retire
April 10, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
March 20, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
February 22, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Tech Stocks Ease On Hot PPI, Yields Rise, Microsoft, Amazon Snap 5-Week Positive Streak: What's Driving Markets Friday?
February 16, 2024
Wall Street takes pause after stronger-than-expected producer inflation report, potentially delaying Fed rate cuts and impacting major indices and stocks.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday
February 16, 2024
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
February 15, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024
January 24, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
10 S&P 500 Stocks With Over 40% Upside Potential: Hidden Gems Or Value Traps?
January 23, 2024
S&P 500 index surges to new highs, driven by AI, earnings optimism, and Fed rate cuts. Top 10 stocks with significant upside potential for 2024 rally.
Via
Benzinga
Topics
Artificial Intelligence
Economy
Stocks
Exposures
Artificial Intelligence
Interest Rates
US Equities
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference
January 02, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets
December 07, 2023
Fifty-six percent of S&P 500 companies have shown positive performance in 2023 and 44% retreated Moderna Inc. (NASDAQ: MRNA) offers the highest upside potential (58%).
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Black Friday On Wall Street: 10 S&P 500 Stocks Trading At 40%+ Discount From Analysts' Expectations
November 24, 2023
Several S&P 500 stocks are trading at discounts of over 40% compared to analysts' price targets, offering potential upside, but caution is needed.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Clinical Diagnostic-Focused Bio-Rad Stock Trading Lower Today?
October 27, 2023
Bio-Rad Laboratories Inc (NYSE: BIO) shares are trading lower after the company lowered its annual revenue growth forecast, citing the uncertain pace of the biopharma sector's recovery and the
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.